Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles
- PMID: 15451177
- DOI: 10.1016/j.antiviral.2004.04.007
Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles
Abstract
Retroviral integrases catalyze two of the steps of insertion of proviral DNA into the host genomic DNA. Inhibitors that target the second step, strand transfer into the host DNA, have been demonstrated to have antiviral activity in cell culture. We describe two classes of HIV-1 integrase inhibitors that block strand transfer, one based on a naphthamidine core and one on a benzimidazole core. While the naphthamidine compounds showed some propensity to interact with the DNA substrate, both classes were shown to bind directly to integrase. The naphthamidine compounds showed activity in cell culture, and a direct effect on integrase was indicated by an increase in 2-LTR products in the presence of a naphthamidine compound. These two classes of compounds represent potential starting points for the development of new classes of integrase inhibitors.
Similar articles
-
The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.Biochem Pharmacol. 2004 May 1;67(9):1751-61. doi: 10.1016/j.bcp.2004.01.015. Biochem Pharmacol. 2004. PMID: 15081874
-
Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.Biochemistry. 2007 Sep 25;46(38):10776-89. doi: 10.1021/bi7006542. Epub 2007 Aug 29. Biochemistry. 2007. PMID: 17725323
-
Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.Bioorg Med Chem Lett. 2006 Jun 1;16(11):2920-4. doi: 10.1016/j.bmcl.2006.03.010. Epub 2006 Mar 20. Bioorg Med Chem Lett. 2006. PMID: 16546383
-
HIV type 1 integrase inhibitors: from basic research to clinical implications.AIDS Rev. 2008 Jul-Sep;10(3):172-89. AIDS Rev. 2008. PMID: 18820719 Review.
-
Characterization and structural analysis of HIV-1 integrase conservation.AIDS Rev. 2009 Jan-Mar;11(1):17-29. AIDS Rev. 2009. PMID: 19290031 Review.
Cited by
-
Recent developments in human immunodeficiency virus-1 latency research.J Gen Virol. 2013 May;94(Pt 5):917-932. doi: 10.1099/vir.0.049296-0. Epub 2013 Jan 30. J Gen Virol. 2013. PMID: 23364195 Free PMC article. Review.
-
Deep molecular characterization of HIV-1 dynamics under suppressive HAART.PLoS Pathog. 2011 Oct;7(10):e1002314. doi: 10.1371/journal.ppat.1002314. Epub 2011 Oct 27. PLoS Pathog. 2011. PMID: 22046128 Free PMC article.
-
Design and synthesis of anti-MRSA benzimidazolylbenzene-sulfonamides. QSAR studies for prediction of antibacterial activity.Molecules. 2010 Dec 29;16(1):175-89. doi: 10.3390/molecules16010175. Molecules. 2010. PMID: 21191320 Free PMC article.
-
HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.Retrovirology. 2016 Jan 5;13:1. doi: 10.1186/s12977-015-0234-9. Retrovirology. 2016. PMID: 26728316 Free PMC article.
-
Efficient copper-based DNA cleavers from carboxylate benzimidazole ligands.J Biol Inorg Chem. 2018 Oct;23(7):1165-1183. doi: 10.1007/s00775-018-1598-9. Epub 2018 Aug 3. J Biol Inorg Chem. 2018. PMID: 30076466
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources